SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-20-236406
Filing Date
2020-08-31
Accepted
2020-08-31 17:28:29
Documents
5
Group Members
AVALANCHE MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d66298dsctoc.htm SC TO-C 22955
2 EX-99.2 d66298dex992.htm EX-99.2 31118
3 EX-99.3 d66298dex993.htm EX-99.3 17925
4 EX-99.4 d66298dex994.htm EX-99.4 9781
5 EX-99.5 d66298dex995.htm EX-99.5 9459
  Complete submission text file 0001193125-20-236406.txt   92918
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filed by) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90051 | Film No.: 201152652
SIC: 2834 Pharmaceutical Preparations